for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

MTBC Inc

MTBCP.O

Latest Trade

27.21USD

Change

0.00(0.00%)

Volume

17,084

Today's Range

27.20

 - 

27.32

52 Week Range

25.78

 - 

28.21

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest News

BRIEF-Mtbc Reports Q1 Gaap Loss Per Share $0.06

* Q1 GAAP LOSS PER SHARE $0.06 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-MTBC To Buy Assets Of Orion Healthcorp And 13 Of Its Affiliate Companies

* MTBC SIGNS ACQUISITION AGREEMENT THAT COULD INCREASE REVENUES BY AT LEAST 50%

BRIEF-Medical Transcription Billing Says On May 4, Executed Apa To Buy Assets Of Orion Healthcorp, 13 Of Its Affiliates

* MEDICAL TRANSCRIPTION BILLING SAYS ON MAY 4, EXECUTED APA TO BUY ASSETS OF ORION HEALTHCORP, 13 OF ITS AFFILIATES - SEC FILING

CORRECTED-BRIEF-MTBC Announces $10.5 Million Public Offering Of Non Convertible Preferred Stock (April 4)

* ANNOUNCES $10.5 MILLION PUBLIC OFFERING OF NON-CONVERTIBLE PREFERRED STOCK

BRIEF-Medical Transcription Billing Says Offering 400,000 Shares Of 11 Pct Series A Cumulative Redeemable Perpetual Preferred Stock

* MEDICAL TRANSCRIPTION BILLING CORP SAYS OFFERING 400,000 SHARES OF OUR 11% SERIES A CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK - SEC FILING Source text: [https://bit.ly/2GlOgoL] Further company coverage:

BRIEF-MTBC Reports Q4 Adjusted Non-GAAP Earnings Per Share $0.13

* "ANTICIPATE SPENDING MORE ON SALES AND MARKETING IN 2018 THAN 3.5% OF REVENUE WE SPENT IN 2017" Source text for Eikon: Further company coverage:

BRIEF-MTBC Announces $3.9 Mln Public Offering Of Non-Convertible Preferred Stock

* MTBC ANNOUNCES $3.9 MILLION PUBLIC OFFERING OF NON-CONVERTIBLE PREFERRED STOCK

BRIEF-Medical Transcription Billing CEO Mahmud Ul Haq Reports Open Market Purchase Of 30,000 Shares Of Common Stock

* MEDICAL TRANSCRIPTION BILLING CEO MAHMUD UL HAQ REPORTS OPEN MARKET PURCHASE OF 30,000 SHARES OF CO'S COMMON STOCK ON DEC 1 AT 2.93 PER SHARE - SEC FILING Source text: (http://bit.ly/2jNvmdb) Further company coverage:

BRIEF-MTBC Says Mahmud Haq Will Assume Role Of Executive Chairman Of Board Of Directors

* MEDICAL TRANSCRIPTION BILLING CORP - MAHMUD HAQ WILL ASSUME ROLE OF EXECUTIVE CHAIRMAN OF BOARD OF DIRECTORS

BRIEF-MTBC Comments On 2017 Guidance And 2018 Outlook

* EXPECT NEW CLIENT TO REPRESENT APPROXIMATELY 10% OF 2018 REVENUE Source text for Eikon: Further company coverage:

BRIEF-MTBC reports Q3 adjusted non-GAAP loss per share $0.03

* Q3 revenue rose 41 percent to $7.5 million Source text for Eikon: Further company coverage:

BRIEF-MTBC secures $5 million credit facility with Silicon Valley Bank

* MTBC secures $5 million credit facility with Silicon Valley Bank Source text for Eikon: Further company coverage:

BRIEF-MTBC announces final $5 mln MediGain acquisition payment

* MTBC announces final $5 million MediGain acquisition payment Source text for Eikon: Further company coverage:

BRIEF-MTBC announces $6 million public offering of non-convertible preferred stock

* Medical Transcription Billing Corp - co announced pricing of public offering of 240,000 shares for $25 per share Source text for Eikon: Further company coverage:

BRIEF-Medical Transcription Billing Corp files for offering of series A cumulative redeemable perpetual preferred stock

* Medical Transcription Billing Corp files for offering of 200,000 shares of co's 11% series a cumulative redeemable perpetual preferred stock - SEC filing Source text: (http://bit.ly/2x5Rd5S) Further company coverage:

BRIEF-Medical Transcription Billing fully repays $8 mln term loans

* Medical Transcription Billing Corp-fully repaid $8 million term loans from Opus Bank which had outstanding balances of about $7.3 million as of Jan 1, 2017 Source text for Eikon: Further company coverage:

BRIEF-Medical Transcription Billing to become Infinity Diagnostic Labs' healthcare IT and revenue cycle management vendor​

* Medical Transcription Billing Corp - has been selected by Infinity Diagnostic Labs, as its healthcare it and revenue cycle management vendor Source text for Eikon: Further company coverage:

BRIEF-MTBC reports Q2 loss per share of $0.20

* MTBC reports second quarter 2017 results, reaffirms 2017 guidance

BRIEF-Medical Transcription Billing well positioned to meet or exceed full-year 2017 guidance

* Medical Transcription Billing -Well positioned to meet or exceed full-year 2017 guidance of $30-31 million of revenue with $2.0- 2.5 million of positive adjusted EBITDA Source text for Eikon: Further company coverage:

BRIEF-MTBC announces acquisition of regional revenue cycle management company

* MTBC announces acquisition of regional revenue cycle management company

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up